HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Thomas Chin Selected Research

Alemtuzumab (Campath)

6/2007Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation.
10/2004Campath-1H in renal transplantation: The University of Wisconsin experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Thomas Chin Research Topics

Disease

5Death (Near-Death Experience)
11/2005 - 01/2002
3Brain Death (Brain Dead)
11/2005 - 01/2004
3Delayed Graft Function
10/2004 - 01/2004
2Pathologic Constriction (Stenosis)
11/2005 - 01/2004
1End Stage Liver Disease
09/2007
1Autoimmune Diseases (Autoimmune Disease)
06/2007
1Pneumoperitoneum
10/2006
1Liver Abscess
11/2005
1Hemorrhage
02/2005
1HELLP Syndrome
02/2005
1Pre-Eclampsia (Preeclampsia)
02/2005
1Rupture
02/2005
1Necrosis
02/2005
1Hemolysis
02/2005
1Biliary Atresia
06/2004
1Lymphocele
06/2003
1Liver Diseases (Liver Disease)
01/2002
1Infections
01/2002

Drug/Important Bio-Agent (IBA)

4dicarboxydine (DCD)IBA
11/2005 - 01/2004
2Alemtuzumab (Campath)FDA Link
06/2007 - 10/2004
1Mannitol (Osmitrol)FDA LinkGeneric
10/2006
1Dopamine (Intropin)FDA LinkGeneric
10/2006
1EnzymesIBA
02/2005
1CreatinineIBA
09/2004
1LipidsIBA
06/2003
1Sirolimus (Rapamycin)FDA Link
06/2003
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2002

Therapy/Procedure

6Liver Transplantation
09/2007 - 01/2002
3Transplantation
11/2005 - 01/2004
2Kidney Transplantation
11/2005 - 09/2004
1Therapeutics
01/2002